Payden & Rygel’s Elevance Health ELV Stock Holding History

Payden & Rygel’s Portfolio ELV Stock Details ELV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$18.8M	Sell
2022 Q4	$34.8M	Buy
2022 Q3	$30.2M	Buy
2022 Q2	$18.9M	Buy
2022 Q1	$1.87M	Buy
2021 Q4	$881K	Sell
2021 Q3	$24.3M	Sell
2021 Q2	$24.9M	Buy
2021 Q1	$23.4M	Buy